|
|
||||||||
Ann Thorac Surg 1997;63:1326-1332
© 1997 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Department of Surgery, and Division of Cardiac Anesthesiology, Department of Anesthesiology, University of Washington, Seattle, Washington
Accepted for publication November 27, 1996.
Background. Perfluorocarbon emulsion has proved beneficial in the prevention and amelioration of experimental air embolism. We examined whether the addition of perfluorocarbon to the prime solution could lead to a reduction in the incidence and severity of neurologic injury after the formation of a massive air embolism during cardiopulmonary bypass.
Methods. Fourteen pigs underwent bypass in which either a crystalloid prime solution or a perfluorocarbon prime solution (10 mL/kg) was used. Ten minutes into bypass a bolus (5 mL/kg) of air or saline (control) was delivered via the carotid artery. The resulting cerebral infarcts were graded on the basis of the findings in triphenyltetrazolium chloridestained cerebral sections. Colored microspheres were used to measure cerebral blood flow. Bitemporal electroencephalography was used to evaluate cerebral function.
Results. Cerebral infarction was not found in the perfluorocarbon-air group (0 of 5 animals), as compared with its occurrence in 3 of the 5 animals in the crystalloid-air group. Cerebral blood flow was also maintained or increased in the perfluorocarbon-air group (p < 0.05), and the electroencephalogram total power showed less of a decrease and recovered more completely (p < 0.05) than it did in the crystalloid-air group.
Conclusions. The addition of perfluorocarbon emulsion to the cardiopulmonary bypass prime solution leads to a reduction in the incidence and severity of neurologic injury after the formation of a massive air embolism during bypass.
This article has been cited by other articles:
![]() |
B. D. Spiess Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics J Appl Physiol, April 1, 2009; 106(4): 1444 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. de Lange, K. Yoshitani, A. D. Proia, G. B. Mackensen, and H. P. Grocott Perfluorocarbon Administration During Cardiopulmonary Bypass in Rats: An Inflammatory Link to Adverse Outcome? Anesth. Analg., January 1, 2008; 106(1): 24 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshitani, F. de Lange, Q. Ma, H. P. Grocott, and G. B. Mackensen Reduction in Air Bubble Size Using Perfluorocarbons During Cardiopulmonary Bypass in the Rat Anesth. Analg., November 1, 2006; 103(5): 1089 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hill, H. P. Grocott, B. J. Leone, W. D. White, M. F. Newman, and Neurologic Outcome Research Group of the Duke Hear Cerebral Physiology of Cardiac Surgical Patients Treated with the Perfluorocarbon Emulsion, AF0144 Ann. Thorac. Surg., October 1, 2005; 80(4): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barak and Y. Katz Microbubbles: Pathophysiology and Clinical Implications Chest, October 1, 2005; 128(4): 2918 - 2932. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Dye, R. P. Cochran, K. S. Kunzelman, C. R. Vocelka, Ccp, H. Akimoto, R. Thomas, L. O. Soltow, and B. D. Spiess Macroscopic Bubbles From Dissolved Nitrogen During CPB Ann. Thorac. Surg., November 1, 1997; 64 (5): 1527 - 1527. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |